共 50 条
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms
被引:0
|作者:
Brennan-Cook, Jill
[1
]
Rein, Lindsay
[2
]
Kuykendall, Andrew
[3
]
Johnson, Natasha
[3
]
Koch, Amie
[4
]
Taylor, Allison O.
[2
]
Jones, Christopher A.
[5
]
Leblanc, Thomas W.
[2
]
机构:
[1] Duke Univ, Sch Nursing, DUMC 3322,307 Trent Dr, Durham, NC 27710 USA
[2] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC 27710 USA
[3] Moffit Canc Ctr, Dept Malignant Hematol, Tampa, FL USA
[4] Duke Univ, Sch Nursing, Bayada Pediat, Durham, NC 27710 USA
[5] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA
关键词:
disease progression;
essential thrombocythemia;
myelofibrosis;
myeloproliferative neoplasms;
palliative care;
polycythemia vera;
STEM-CELL TRANSPLANTATION;
INTERNATIONAL PROGNOSTIC SCORE;
ESSENTIAL THROMBOCYTHEMIA;
POLYCYTHEMIA-VERA;
SYMPTOM BURDEN;
RUXOLITINIB;
MYELOFIBROSIS;
SURVIVAL;
RISK;
VALIDATION;
D O I:
10.1089/jpm.2024.0221
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
Myeloproliferative neoplasms (MPNs) are a group of rare chronic progressive blood cancers that vary widely in clinical presentation, yet all patients have a risk of disease progression and thrombotic complications. Diseases include primary myelofibrosis, polycythemia vera, and essential thrombocythemia. With current treatment approaches, most patients live a prolonged life, but many experience a complex of symptoms that negatively influence their functional status and quality of life. Although significant advances have been made in preventing arterial and venous complications while mitigating inflammatory processes, comprehensive palliative care can help address unmet complex physical and psychosocial needs on a long-term basis. This article, created by a multidisciplinary group of providers, offers an overview of MPNs so palliative care clinicians can better support patients with these hematologic cancers.
引用
收藏
页码:257 / 264
页数:8
相关论文